Kodiak Sciences (KOD) Enterprise Value (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Enterprise Value came in at -$169.5 million in Q1 2026, down 22.09% YoY from -$217.6 million in Q1 2025, and up 19.22% on a QoQ basis from -$209.9 million in Q4 2025.
Kodiak Sciences (KOD) Enterprise Value (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Enterprise Value data on file, last reported at -$169.5 million in Q1 2026.
- Quarterly Enterprise Value fell 22.09% year-over-year to -$169.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$169.5 million (down 22.09% YoY) and the FY2025 annual result came in at -$209.9 million, down 24.86% from the prior year.
- Enterprise Value improved to -$169.5 million in Q1 2026, from -$209.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$72.0 million in Q3 2025 to a low of -$671.7 million in Q1 2022.
- A 5-year average of -$308.8 million and a median of -$245.9 million in 2024 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 63.59% in 2025, down 24.86% in 2025.
- Tracing KOD's Enterprise Value over 5 years: stood at -$485.3 million in 2022, then surged by 41.16% to -$285.5 million in 2023, then soared by 41.13% to -$168.1 million in 2024, then decreased by 24.86% to -$209.9 million in 2025, then advanced by 19.22% to -$169.5 million in 2026.
- The last three Enterprise Value figures came in at -$169.5 million (Q1 2026), -$209.9 million (Q4 2025), and -$72.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | -125.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -125.90 Mn |
| Mar 31, 2026 | -169.53 Mn |
| Dec 31, 2025 | -209.86 Mn |
| Sep 30, 2025 | -72.04 Mn |
| Jun 30, 2025 | -104.17 Mn |
| Mar 31, 2025 | -138.85 Mn |
| Dec 31, 2024 | -168.07 Mn |
| Sep 30, 2024 | -197.86 Mn |
| Jun 30, 2024 | -219.23 Mn |
| Mar 31, 2024 | -245.92 Mn |
| Dec 31, 2023 | -285.51 Mn |
| Sep 30, 2023 | -345.67 Mn |
| Jun 30, 2023 | -378.67 Mn |
| Mar 31, 2023 | -421.19 Mn |
| Dec 31, 2022 | -485.26 Mn |
| Sep 30, 2022 | -537.40 Mn |
| Jun 30, 2022 | -597.88 Mn |
| Mar 31, 2022 | -671.73 Mn |
| Dec 31, 2021 | -731.51 Mn |
| Sep 30, 2021 | -799.25 Mn |